Cartilaginous airway wall dimensions and airway resistance in cystic fibrosis lungs

European Respiratory Journal

Volumn 15, Issue 4, 2000, Pages 735-742

  Tiddens, H A W M ^a,b   Koopman, L P ^a   Lambert, R K ^c   Elliott, W M ^d   Hop, W C J ^b   Van Der Mark, T W ^e   De Boer, W J ^e   De Jongste, J C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c MASSEY UNIVERSITY   (New Zealand)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Airflow obstruction; Airway epithelium; Airway inflammation; Airway remodelling; Bronchial responsiveness; Cystic fibrosis

Indexed keywords

ADOLESCENT; ADULT; AGED; AIRWAY OBSTRUCTION; AIRWAY RESISTANCE; ARTICLE; AUTOPSY; BRONCHUS MUCOSA; BRONCHUS REACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG LOBECTOMY; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AIRWAY OBSTRUCTION; AIRWAY RESISTANCE; BRONCHIAL HYPERREACTIVITY; BRONCHOCONSTRICTOR AGENTS; CARTILAGE; CHILD; CULTURE TECHNIQUES; CYSTIC FIBROSIS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; LUNG; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; MUSCLE, SMOOTH; RESPIRATORY FUNCTION TESTS; RESPIRATORY MUSCLES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0034081090     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.15d18.x     Document Type: Article

References (46)

1. Moreno RH, Hogg JC, Paré PD. Mechanics of airway narrowing. Am Rev Respir Dis 1986; 133: 1171-1180.
2. James AL, Paré PD, Hogg JC. The mechanics of airway narrowing in asthma. Am Rev Respir Dis 1989; 139: 242-246.
3. Bedrossian CWM, Greenberg SD, Singer DB, Hansen JJ, Rosenberg HS. The lung in cystic fibrosis: a quantitative study including prevalence of pathologic findings among different age groups. Hum Pathol 1976; 7: 195-204.
4. Tomashefski JF, Bruce M, Goldberg HI, Dearborn DG. Regional distribution of macroscopic lung disease in cystic fibrosis. Am Rev Respir Dis 1986; 133: 535-540.
5. Sobonya RE, Taussig LM. Quantitative aspects of lung pathology in cystic fibrosis. Am Rev Respir Dis 1986; 134: 290-295.
6. Dovey M, Wisseman CL, Roggli VL, Roomans GM, Shelburne JD, Spock A. Ultrastructural morphology of the lung in cystic fibrosis. J Submicrosc Cytol Pathol 1989; 21: 521-534.
7. Leigh MW, Kylander JE, Yankaskas JR, Boucher TC. Cell proliferation in bronchial epithelium and submucosal glands of cystic fibrosis patients. Am J Respir Cell Biol 1995; 12: 605-612.
8. Hulsmann AR, De Jongste JC. Modulation of airway responsiveness by the airway epithelium in humans, putative mechanisms. Clin Exp Allergy 1996; 26: 1236-1242.
9. Tiddens HAWM, Paré PD, Hogg JC, Hop WCJ, Lambert R, de Jongste JC. Cartilaginous airway dimensions and airflow obstruction in human lungs. Am J Respir Crit Care Med 1995; 152: 260-266.
10. Kuwano K, Bosken CH, Paré PD, Bai TR, Wiggs BR, Hogg JC. Small airways dimensions in asthma and chronic obstructive pulmonary disease. Am Rev Respir Dis 1993; 148: 1220-1225.
11. Nagai A, Thurlbeck WM, Konno K. Responsiveness and variability of airflow obstruction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 151: 635-639.
12. Tiddens HAWM, Boogaard JM, de Jongste JC, Hop WCJ, Coxson HO, Paré PD. Physiological and morphological determinants of maximal expiratory flow in chronic obstructive lung disease. Eur Respir J 1996; 9: 1785-1794.
13. Haraguchi M, Shimura S, Shirato K. Morphometric analysis of bronchial cartilage in chronic obstructive pulmonary disease and bronchial asthma. Am J Respir Crit Care Med 1999; 159: 1005-1013.
14. Tiddens HAWM. Structure and function of chronically inflamed human airways. Thesis Erasmus University Rotterdam, Rotterdam, 1997.
15. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J 1993; 6: 5-40.
16. Zapletal A, Samanek M, Paul T. Lung function in children and adolescents. Progress in respiration research. Basel, Karger, 1987.
17. Bai A, Eidelman DH, Hogg JC, et al. Proposed nomenclature for quantifying subdivisions of the bronchial wall. J Appl Physiol 1994; 77: 1011-1014.
18. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i: 307-310.
19. Feldman HA. Families of lines: random effects in linear regression analysis. J Appl Physiol 1988; 64: 1721-1732.
20. Schluchter MD, Module 5V. In: Dixon WJ, ed. BMDP statistical software manual. Berkeley, University of California press, 1990; pp. 1207-1244.
21. Bosken CH, Wiggs BR, Paré PD, Hogg JC. Small airway dimensions in smokers with obstruction to airflow. Am Rev Respir Dis 1990; 142: 563-570.
22. Wiggs BR, Bosken C, Paré PD, James A, Hogg JC. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 145: 1251-1258.
23. Lambert RK, Wiggs BR, Kuwano K. Functional significance of increased airway smooth muscle in asthma and COPD. J Appl Physiol 1993; 74: 2771-2781.
24. Hammersley JR, Olson DE. Physical models of the smaller pulmonary airways. J Appl Physiol 1992; 72: 2402-2414.
25. Jeffery PK. Morphology of the airway wall in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 143: 1152-1158. (discussion 1161).
26. Baltimore R, Christie C, Smith W. Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Am Rev Respir Dis 1989; 140: 1650-1661.
27. de Bentzmann S, Roger P, Puchell E. Pseudomonas aeruginosa adherence to remodelling respiratory epithelium. Eur Respir J 1996; 9: 2145-2150.
28. Mellis CM, Levison H. Bronchial reactivity in cystic fibrosis. Pediatrics 1978; 61: 446-450.
29. Mitchell I, Corey M, Woenne R, Krastins IRB, Levison H. Bronchial hyperreactivity in cystic fibrosis and asthma. J Pediatr 1978; 93: 744-748.
30. Ormerod LP, Thomson RA, Anderson CM, Stableforthe DE. Reversible airway obstruction in cystic fibrosis. Thorax 1980; 35: 768-772.
31. Tobin MJ, Maguire O, Tempany E, Fitzgerald MX. Atopy and bronchial reactivity in older patients with cystic fibrosis. Thorax 1980; 35: 807-813.
32. van Asperen P, Mellis CM, South RT, Simpson SJ. Bronchial reactivity in cystic fibrosis with normal pulmonary function. Am J Dis Child 1981; 135: 815-819.
33. Eggleston PA, Rosenstein BJ, Stackhouse CM, Mellits ED, Baumgardner RA. A controlled trial of long-term bronchodilator therapy in cystic fibrosis. Chest 1991; 99: 1088-1092.
34. van Haren EHJ, Lammers J-WJ, Festen J, van Herwaarden CLA. Bronchial vagal tone and responsiveness to histamine, exercise and bronchodilators in adult patients with cystic fibrosis. Eur Respir J 1992; 5: 1083-1088.
35. Larsen GL, Renz H, Loader JE, Bradley KL, Gelfand EW. Airway response to electrical field stimulation in sensitized inbred mice. Passive transfer of increased responsiveness with peribronchial lymph nodes. J Clin Invest 1992; 89: 747-752.
36. Lambert RK, Paré PD. Lung parenchymal shear modulus, airway wall remodeling, and bronchial hyperresponsiveness. J Appl Physiol 1997; 83: 140-147.
37. Thomson RJ, Bramley AM, Schellenberg RR. Airway muscle sterology: implications for increased shortening in asthma. Am J Respir Crit Care Med 1996; 154: 749-757.
38. Lambert RK, Codd SL, Alley MR, Pack RJ. Physical determinants of bronchial mucosal folding. J Appl Physiol 1994; 77: 1206-1216.
39. Wilson JW, Li X, Pain MC. The lack of distensibility of asthmatic airways. Am Rev Respir Dis 1993; 148: 806-809.
40. Larsen G, Barron RJ, Cotton EK, Brooks JG. A comparative study of inhaled atropine sulfate and isoproterenol hydrochloride in cystic fibrosis. Am Rev Respir Dis 1979; 119: 399-407.
41. Hulsmann AR, Raatgeep HR, Den Hollander JC, et al. Oxidative epithelial damage produces hyperresponsiveness of human peripheral airways. Am J Respir Crit Care Med 1994; 149: 519-525.
42. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989; 140: 1745-1753.
43. Konig P, Poehler J, Barbero GJ. A placebo-controlled, double-blind trial of the long-term effects of albuterol administration in patients with cystic fibrosis. Pediatr Pulmonol 1998; 25: 32-36.
44. Konstan MW, Byard PJ, Hopel CL, Davis PB. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 1995; 332: 848-854.
45. Eigen H, Rosenstein BJ, FitzSimmons S, Schidlow DV, and the Cystic Fibrosis Foundation prednisone trial group. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. J Pediatr 1995; 126: 515-523.
46. Bisgaard H, Pedersen SS, Nielsen KG, et al. Controlled trial of inhaled budesonide in patients with cystic fibrosis and chronic bronchopulmonary Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 1997; 156: 1190-1196.